Management of congestive heart failure in the elderly

M J Malloy1, L M Lopez

  • 1Department of Pharmacy Practice, College of Pharmacy, University of Florida, Gainesville 32610.

Insights

Optimal congestive heart failure (CHF) treatment remains debated, especially for elderly patients. Current evidence suggests enalapril or hydralazine/isosorbide dinitrate improve survival, questioning traditional digitalis glycoside use.

Area of Science:

  • Cardiology
  • Pharmacology
  • Geriatrics

Background:

  • The optimal treatment strategy for congestive heart failure (CHF) is not universally agreed upon, particularly in elderly populations.
  • Existing research challenges the routine use of digitalis glycosides as a first-line therapy for chronic CHF.
  • Diuretics, specifically thiazide diuretics, have been proposed as initial treatment options by some clinicians.

Purpose of the Study:

  • To review current evidence on therapeutic agents for congestive heart failure (CHF).
  • To evaluate the efficacy of different drug classes in managing chronic CHF, focusing on mortality reduction.
  • To identify areas requiring further research in CHF pharmacotherapy.

Main Methods:

  • Review of existing clinical studies and pharmacological data.
  • Analysis of evidence regarding the impact of digitalis glycosides, diuretics, and vasodilators on CHF outcomes.
  • Synthesis of findings to inform treatment guidelines.

Main Results:

  • Drug therapy with enalapril has demonstrated a reduction in mortality associated with chronic CHF.
  • Combination therapy with hydralazine and isosorbide dinitrate has also shown efficacy in reducing CHF-related mortality.
  • The definitive roles of digitalis glycosides and diuretics in current CHF management require further investigation.

Conclusions:

  • Current evidence supports the use of enalapril or hydralazine/isosorbide dinitrate for reducing mortality in chronic CHF.
  • The established role of digitalis glycosides in CHF treatment warrants re-evaluation.
  • Further research is necessary to elucidate the precise therapeutic positioning of diuretics, digitalis glycosides, and vasodilators in comprehensive CHF management.

Related Concept Videos

Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...